Delisting risk
BioCardia
Develops cell therapies and catheter systems for heart and lung diseases.
$1.18
After-hours close+0.00 (+0.36%)
At close$1.18(+0.85%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 4.61%686.6K sharesInsiders 10.85%1.61M sharesOther 84.54%12.58M shares
Shares outstanding 14.88M · Float 10.19M · 68.5% free float
A Form 4 total here can count shares the filer formally disclaims — an award voted by proxy, for instance — which the holder's own Schedule 13D/G excludes, so where the two disagree the schedule's smaller figure is used.
Institutions13F, as of Mar 31, 2026
18 holders · 686.6K shares · 6 new positions · 11 increased · 2 reduced · 8 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| CM Management, LLC | 130.0K | 0.87% | 0 | May 8, 2026 |
| Vanguard Capital Management LLC | 124.6K | 0.84% | +124.6Knew | May 15, 2026 |
| Geode Capital Management, LLC | 94.3K | 0.63% | +28.3K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 66.3K | 0.45% | +66.3Knew | May 8, 2026 |
| Citadel Advisors LLC | 63.4K | 0.43% | −30.9K | May 15, 2026 |
| Susquehanna International Group, LLP | 38.8K | 0.26% | +18 | May 15, 2026 |
| Pingora Partners LLC | 35.7K | 0.24% | +32.7K | May 15, 2026 |
| Brown Advisory Inc | 35.5K | 0.24% | 0 | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Thomas A. Satterfield, Jr. | 9.90% | 592.1K | 13G | Aug 13, 2025 ↗ |
| Lincoln Alternative Strategies LLC | 7.54% | 800.0K | 13G | Sep 19, 2025 ↗ |
| Blank Andrew Scott | 5.50% | 278.3K | 13D | May 22, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Simon H. Stertzer | director | 757.4K | 5.09% | Jun 24, 2026 |
| Peter Altman | director, officer: President and CEO | 381.1K | 2.56% | Aug 18, 2026 |
| Andrew Scott Blank | director | 278.3K | 1.87% | Sep 23, 2025 |
| David McClung | officer: Chief Financial Officer | 114.2K | 0.77% | Jul 7, 2026 |
| Edward M. Gillis | officer: Senior Vice President, Devices | 54.1K | 0.36% | Jul 7, 2026 |
| Richard M. Krasno | director | 16.3K | 0.11% | Apr 28, 2025 |
| Bill Facteau | director | 13.1K | 0.09% | Apr 25, 2025 |
4 ten-percent owners hold 163.0K shares by Form 4, outside the officers-and-directors figure above · 20 people have not refiled in the last 18 months (130.6K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 17, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 5,400 | $0.9300 | 381,115 |
| Aug 13, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 1,900 | $0.9200 | 375,785 |
| Jul 29, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 5,000 | $0.7800 | 373,885 |
| Jul 17, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 500 | $0.8300 | 368,885 |
| Jul 14, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 2,800 | $0.8800 | 366,885 |
| Jul 15, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 1,500 | $0.8600 | 368,385 |
| Jul 8, 2026 | Peter Altmandirector, officer: President and CEO | Purchase · 2 lots | 10,900 | $0.9673 | 367,485 |
| Jul 9, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 1,000 | $0.9000 | 368,485 |
| Jul 10, 2026 | Peter Altmandirector, officer: President and CEO | Purchase | 1,000 | $0.9400 | 369,485 |
| Jun 22, 2026 | Simon H. Stertzerdirector | Purchase | 70,200 | $0.9200 | 127,338 |
CongressHouse and Senate disclosures
Not reported.